New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27

Type 1 diabetes (T1D) is a pancreatic beta cell specific autoimmune disease. One of the most significant current discussions in T1D studies is therapy. Since the conventional therapy, islet transplantation and external insulin, e.g., cannot prevent the destructive autoimmune process against original...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Adv Pharm Bull
Päätekijät: Zamani, Fatemeh, Almasi, Shohreh, Kazemi, Tohid, Jahanban Esfahlan, Rana, Aliparasti, Mohammad Reza
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Tabriz University of Medical Sciences 2015
Aiheet:
Editorial
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4708029/
https://ncbi.nlm.nih.gov/pubmed/26793604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/apb.2015.081
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia